1. Lymphocyte‐activation gene‐3, an important immune checkpoint in cancer. Issue 9 (25th August 2016) Authors: He, Yayi; Rivard, Christopher J.; Rozeboom, Leslie; Yu, Hui; Ellison, Kim; Kowalewski, Ashley; Zhou, Caicun; Hirsch, Fred R. Journal: Cancer science Issue: Volume 107:Issue 9(2016) Page Start: 1193 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Loss of STING expression is prognostic in non–small cell lung cancer. Issue 6 (31st January 2022) Authors: Lohinai, Zoltan; Dora, David; Caldwell, Charles; Rivard, Christopher J.; Suda, Kenichi; Yu, Hui; Rivalland, Gareth; Ellison, Kim; Rozeboom, Leslie; Dziadziuszko, Rafal; Mitchell, Paul; John, Thomas; Millan, Inigo S.; Ren, Shengxiang; Hirsch, Fred R. Journal: Journal of surgical oncology Issue: Volume 125:Issue 6(2022) Page Start: 1042 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Therapy-induced E-cadherin downregulation alters expression of programmed death ligand-1 in lung cancer cells. (July 2017) Authors: Suda, Kenichi; Rozeboom, Leslie; Rivard, Christopher J.; Yu, Hui; Ellison, Kim; Melnick, Mary Ann C.; Hinz, Trista K.; Chan, Daniel; Heasley, Lynn E.; Politi, Katerina; Mitsudomi, Tetsuya; Hirsch, Fred R. Journal: Lung cancer Issue: Volume 109(2017) Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Increased EGFR Phosphorylation Correlates with Higher Programmed Death Ligand-1 Expression: Analysis of TKI-Resistant Lung Cancer Cell Lines. (8th October 2017) Authors: Suda, Kenichi; Rozeboom, Leslie; Furugaki, Koh; Yu, Hui; Melnick, Mary Ann C.; Ellison, Kim; Rivard, Christopher J.; Politi, Katerina; Mitsudomi, Tetsuya; Hirsch, Fred R. Other Names: Ruscito Ilary Academic Editor. Journal: BioMed research international Issue: Volume 2017(2017) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. The immune checkpoint, HVEM may contribute to immune escape in non-small cell lung cancer lacking PD-L1 expression. (November 2018) Authors: Ren, Shengxiang; Tian, Qinrui; Amar, Nadav; Yu, Hui; Rivard, Christopher J.; Caldwell, Charles; Ng, Terry L.; Tu, Megan; Liu, Yiwei; Gao, Dexiang; Ellison, Kim; Suda, Kenichi; Rozeboom, Leslie; Rivalland, Gareth; Mitchell, Paul; Zhou, Caicun; Hirsch, Fred R. Journal: Lung cancer Issue: Volume 125(2018) Page Start: 115 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Heterogeneity of EGFR Aberrations and Correlation with Histological Structures: Analyses of Therapy‐Naive Isogenic Lung Cancer Lesions withEGFRMutation. Issue 10 (October 2016) Authors: Suda, Kenichi; Murakami, Isao; Yu, Hui; Ellison, Kim; Shimoji, Masaki; Genova, Carlo; Rivard, Christopher J.; Mitsudomi, Tetsuya; Hirsch, Fred R. Journal: Journal of thoracic oncology Issue: Volume 11:Issue 10(2016) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. EGFR-directed monoclonal antibodies in combination with chemotherapy for treatment of non-small-cell lung cancer: an updated review of clinical trials and new perspectives in biomarkers analysis. (January 2019) Authors: Agustoni, Francesco; Suda, Kenichi; Yu, Hui; Ren, Shengxiang; Rivard, Christopher J.; Ellison, Kim; Caldwell, Charles; Rozeboom, Leslie; Brovsky, Kristine; Hirsch, Fred R. Journal: Cancer treatment reviews Issue: Volume 72(2019) Page Start: 15 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Fibroblast Growth Factor Receptor 1 and Related Ligands in Small-Cell Lung Cancer. Issue 7 (July 2015) Authors: Zhang, Liping; Yu, Hui; Badzio, Andrzej; Boyle, Theresa A.; Schildhaus, Hans-Ulrich; Lu, Xian; Dziadziuszko, Rafal; Jassem, Jacek; Varella-Garcia, Marileila; Heasley, Lynn E.; Kowalewski, Ashley A.; Ellison, Kim; Chen, Gang; Zhou, Caicun; Hirsch, Fred R. Journal: Journal of thoracic oncology Issue: Volume 10:Issue 7(2015) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. MHC class II expression in lung cancer. (October 2017) Authors: He, Yayi; Rozeboom, Leslie; Rivard, Christopher J; Ellison, Kim; Dziadziuszko, Rafal; Yu, Hui; Zhou, Caicun; Hirsch, Fred R Journal: Lung cancer Issue: Volume 112(2017) Page Start: 75 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Fibroblast Growth Factor Receptor 1 and Related Ligands in Small-Cell Lung Cancer. Issue 7 (July 2015) Authors: Zhang, Liping; Yu, Hui; Badzio, Andrzej; Boyle, Theresa A.; Schildhaus, Hans-Ulrich; Lu, Xian; Dziadziuszko, Rafal; Jassem, Jacek; Varella-Garcia, Marileila; Heasley, Lynn E.; Kowalewski, Ashley A.; Ellison, Kim; Chen, Gang; Zhou, Caicun; Hirsch, Fred R. Journal: Journal of thoracic oncology Issue: Volume 10:Issue 7(2015) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗